Navigation Links
Generex Announces Presentations of Novel Vaccine Strategies
Date:9/16/2010

cturing, and use.  The Company is continuing its work toward developing synthetic vaccines for both pandemic and seasonal influenza strains.

About Generex Biotechnology Corporation

Generex is engaged in the research, development and commercialization of drug delivery systems and technologies.  Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).  The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device.  The Company's flagship product, buccal insulin (Generex Oral-lyn™), which has been approved in India, Lebanon, Algeria, and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world.  Antigen Express, Inc. is a wholly owned subsidiary of Generex.  The core platform technologies of Antigen Express comprise immunotherapeutics for the treatment of malignant, infectious, allergic, and autoimmune diseases.  For more information, visit the Generex website at www.generex.com or the Antigen Express website at www.antigenexpress.com.

Safe Harbor Statement

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements can be identified by introductory words such as "expects," "plans," "intends," "believes," "will," "estimates," "forecasts," "projects," or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts.  Forward-loo
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
2. Generex Announces Distribution Agreement for Generex Oral-lyn™ in Chile
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 Aufgrund ... den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt auch ... PDF, verfügbar unter pharmaserialisation.com , zeigt die ... jeweils in Kraft treten. Für international ... länger um das "ob", sondern darum, "wann" sie ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners participated ... to Benefit the Radiation Oncology Institute (ROI), hosted by ... Golden Gate Park in San Francisco.  ... , CEO of Radiation Business Solutions, "but at ... raised over $70,000 for the ROI this year. This ...
(Date:9/19/2014)... Sept. 19, 2014 Intarcia Therapeutics, Inc. ... data for its lead candidate ITCA 650 (continuous subcutaneous ... high baseline HbA1c levels at the 50 th ... of Diabetes (EASD). Data from the open-label, phase 3 ... blood sugar in patients with poorly controlled type 2 ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4
... Ill., April 7, 2011 MinuteClinic, the ... CVS ), has entered into a clinical affiliation ... enhance the high quality, affordable health care services provided ... It is the largest clinical collaboration between a regional ...
... A study published in the journal ... third-largest health system, has achieved remarkable results in eliminating ... and keeping patients safe.  In 2003, Ascension Health set ... Ascension Health has seen consistent improvement over the eight ...
Cached Medicine Technology:New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 2New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 3New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 4Study Highlights Successes of Ascension Health Quality Initiative 2
(Date:9/19/2014)... Hills, CA (PRWEB) September 19, 2014 Bedros ... fastest-selling fitness boot camp in the country. He’s also considered ... thousands of clients, coaching celebrity trainers and serving as a ... knows marketing, and he says that becoming an integral part ... success. , “One of the things that Fit Body Boot ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Quincy ... Theirl, a functional neurologist in private practice in ... of Prevagen Professional in older adults with mild ... – Focus On Brain Health conference on ... is the strongest formula available of the jellyfish ...
(Date:9/19/2014)... September 19, 2014 ShopRite has launched ... School -- with the 2014-2015 school year. The new ... schools via eBoxTops and special donations throughout the year. ... school by registering their ShopRite Price Plus Card at ... for their favorite school. By using their Price Plus ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Atlantic Information ... the authoritative AIS’s Directory of Health Plans — is ... Trends and Data: 2014-2015. The latest edition of the ... re-shaping the health care industry. , With valuable ... issues — from benefit design and management strategies to ...
(Date:9/19/2014)... B. E. Smith, the only full-service leadership ... retained to lead a national chief operating officer ... Rockaway, N.Y. The top executive search firm in the ... than 900 healthcare executives into organizations. , St. ... hospital serving the Rockaway and the Five Towns communities. ...
Breaking Medicine News(10 mins):Health News:New Post from Boot Camp Marketing Expert Bedros Keuilian Explains Importance of Becoming Part of the Community 2Health News:New Post from Boot Camp Marketing Expert Bedros Keuilian Explains Importance of Becoming Part of the Community 3Health News:Prevagen Research Presented at Healthcare Practitioner Conference 2Health News:ShopRite to Donate Up to $1 Million to Local Schools 2Health News:New Book from Atlantic Information Provides Insights Into Trends in the Health Care Industry 2Health News:St. John’s Episcopal Hospital Retains B. E. Smith to Recruit New COO 2Health News:St. John’s Episcopal Hospital Retains B. E. Smith to Recruit New COO 3
... Cholesterol-lowering meds seem to shield against troublesome complication, study ... patients who take cholesterol-lowering statins before cardiac surgery may ... study finds. , Depending on variables such as ... 47 percent of people experience this condition of confusion ...
... mechanics can lead to pain and stiffness , , THURSDAY, Dec. 25 ... back. , To ease the backaches that may have come ... and stretching and straining to put up holiday decorations -- and that ... Association offers a 10-step guide: , Zero ...
... these cells more closely mimic those of humans , , ... found a formula to capture indefinitely the basic embryonic ... cells. , If the findings hold up, scientists ... readily produced, genetically altered strains of rats. As humans ...
... conflicting news reports on the ongoing Baxter Heparin blood thinner controversy. ... of death among several patients, but the agency has also alleged ... patients. , ... Denver, CO (PRWEB) December 25, 2008 ...
... Weber Denture Liner kit is designed to answer questions often ... my loose denture fit better, give me more comfort and ... use of this new always-soft Weber Denture Liner. All ... fit better with this new (Patent Pending) invention. The Weber ...
... at risk for dementia, Parkinsons, researchers say , , WEDNESDAY, ... causes them to kick or cry out during deep sleep ... new Canadian study suggests. , "It,s basically a disorder where ... Dr. Ronald B. Postuma, of McGill University in Montreal. "When ...
Cached Medicine News:Health News:Tips to Ease an Aching Back 2Health News:Scientists May Isolate Stem Cells From Rats, Other Mammals 2Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 2Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 3Health News:LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers 4Health News:New Product Makes Loose Dentures Fit Better 2Health News:New Product Makes Loose Dentures Fit Better 3Health News:Sleep Disorder Could Signal Neurological Disease 2
Anesthetists Precordial Kit incudes one set of 4 chromed plated chest pieces, a reusable monoscope of your choice, and 20 precordial adhesive discs....
Precordial Chestpieces are manufactured from chrome plated brass. Provides a hollow design with deep sound chambers for optimum acoustics....
Adhesive discs sold on rolls of 100, 250, or 1000 each. Manufactured from non-latex medical grade adhesives & material. One size fits all chest pieces....
For accurately monitoring heart and breath sounds....
Medicine Products: